Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.96 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.96 |
| ▸ | GPR84 | Q9NQS5 | 9/20 | 0.68 |
| ▸ | PPARG | P37231 | 7/20 | 0.68 |
| ▸ | PPARD | Q03181 | 7/20 | 0.68 |
| ▸ | PPARA | Q07869 | 7/20 | 0.68 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.68 |
| ▸ | TSHR | P16473 | 4/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | TLR2 | O60603 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | FABP4 | P15090 | 2/20 | 0.68 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.68 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | ESR1 | P03372 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | PDE4A | P27815 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31524395 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL31524404 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL5165908 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL22400854 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL22400866 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL22400909 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL22400855 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL22400849 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL22400946 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL31524392 | 1.00 | FFAR4 (0.96) | FFAR4FFAR1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024063611-A2 | LONG-CHAIN FATTY ACID OR DERIVATIVE THEREOF FOR STRONGLY ACTIVATING FATTY ACID RECEPTOR | 박진병 | 2024-03-28 | — | — | WO | claimed |
| CN-116440112-A | Anti-inflammatory agent containing rare fatty acid | 国立大学法人京都大学 | 2023-07-18 | — | — | CN | claimed |
| US-20210236448-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2021-08-05 | — | — | US | claimed |
| US-20210069141-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2021-03-11 | — | — | US | claimed |
| EP-3707268-A1 | ENZYMATIC METHOD FOR FORMING ESTOLIDES | Produits Chimiques Auxiliaires et de Synthese (FR) | 2020-09-16 | — | — | EP | claimed |
| EP-3097910-B1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | UNIV KYOTO (JP) | 2020-05-13 | — | — | EP | claimed |
| US-20200101036-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2020-04-02 | — | — | US | claimed |
| CN-106456586-A | Metabolism-improving agent comprising rare fatty acid | 国立大学法人京都大学 | 2017-02-22 | — | — | CN | claimed |
| US-20170007564-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-01-12 | — | — | US | claimed |
| US-20170000752-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-01-05 | — | — | US | claimed |
| EP-3097911-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | Kyoto University (JP) | 2016-11-30 | — | — | EP | claimed |
| EP-3097910-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | Kyoto University (JP) | 2016-11-30 | — | — | EP | claimed |
| CN-106163511-A | Anti-inflammatory agent containing rare fatty acid | 国立大学法人京都大学 | 2016-11-23 | — | — | CN | claimed |
| EP-4740753-A1 | INTESTINAL REGULATOR | Noster Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-12522686-B2 | Method for producing hydroxy-fatty-acid-based polyols | U. WINDMÖLLER INNOVATION GMBH & CO. KG (DE) | 2026-01-13 | — | — | US | disclosed |
| US-12491173-B2 | Metabolism-improving agent comprising rare fatty acid | NOSTER INC. (JP) | 2025-12-09 | — | — | US | disclosed |
| WO-2016151115-A1 | PRODUCTION OF FATTY ACID ESTOLIDES | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2016-09-29 | — | — | WO | disclosed |
| US-20150299099-A1 | CERTAIN METATHESIZED NATURAL OIL TRIACYLGLYCEROL POLYOLS FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-22 | — | — | US | disclosed |
| US-20150299099-A1 | CERTAIN METATHESIZED NATURAL OIL TRIACYLGLYCEROL POLYOLS FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-22 | — | — | US | disclosed |
| WO-2015143563-A1 | CERTAIN METATHESIZED NATURAL OIL TRIACYLGLYCEROL POLYOLS FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PHYSICAL PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200101036-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | FASN, ELOVL1, FADS1 | FFAR4 36/4885FFAR1 22/4885GPR84 278/4885 |
| US-20170007564-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | ELOVL1, FASN, FADS1 | FFAR4 34/4885FFAR1 22/4885GPR84 253/4885 |
| US-20210236448-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | FASN, ELOVL1, FADS1 | FFAR4 36/4885FFAR1 22/4885GPR84 278/4885 |
| US-12491173-B2 | Metabolism-improving agent comprising rare fatty acid | FASN, ELOVL1, FADS1 | FFAR4 36/4885FFAR1 22/4885GPR84 278/4885 |
| US-20210069141-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | ELOVL1, ELOVL5, ELOVL3 | FFAR4 14/4885FFAR1 10/4885GPR84 138/4885 |
| US-20170000752-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | ELOVL1, ELOVL5, ELOVL3 | FFAR4 14/4885FFAR1 10/4885GPR84 138/4885 |
| US-20150299099-A1 | CERTAIN METATHESIZED NATURAL OIL TRIACYLGLYCEROL POLYOLS FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PROPERTIES | NOTUM, MGLL, DAGLA | FFAR4 320/4885FFAR1 107/4885GPR84 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.